The effects were confirmed by the immediate flare-up of alanine aminotransferase after drug discontinuation, possibly heralding NASH recurrence.47 According to international guidelines, this makes pioglitazone the long-term treatment of choice for NASH, also useful in patients with cirrhosis of other cause, despite limitations and risks of adverse events. Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.